DNA Test Allows Breast Cancer Patients to Avoid Chemotherapy
Summary
A DNA test called 'Prosigna' can help breast cancer patients avoid chemotherapy by identifying those who will benefit from hormone therapy alone, according to an international study led by University College London.
Key Points
- A DNA gene test called 'Prosigna' can identify which breast cancer patients need chemotherapy and which can avoid it.
- More than two-thirds of breast cancer patients in the trial safely avoided chemotherapy and had high five-year survival rates with hormone therapy alone.
- The study involved over 4,000 patients from multiple countries and was led by University College London.
- These findings were described as 'game-changing' and indicate that thousands of NHS patients could avoid chemotherapy annually.
